119 related articles for article (PubMed ID: 2013106)
1. In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
Denis M
Cell Immunol; 1991 Apr; 134(1):42-53. PubMed ID: 2013106
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
Denis M
Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
[TBL] [Abstract][Full Text] [Related]
3. Mouse T cell clones against Mycobacterium avium: identification of clones that modify resistance against atypical mycobacteria infection.
Denis M
J Leukoc Biol; 1992 Jan; 51(1):7-12. PubMed ID: 1740647
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Mycobacterium avium growth in murine macrophages: reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4.
Denis M; Gregg EO
J Leukoc Biol; 1991 Jan; 49(1):65-72. PubMed ID: 1898613
[TBL] [Abstract][Full Text] [Related]
5. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
Appelberg R; Sarmento AM
Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
[TBL] [Abstract][Full Text] [Related]
6. Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.
Denis M
Infect Immun; 1991 May; 59(5):1857-9. PubMed ID: 2019446
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.
Castro AP; Aguas AP; Silva MT
Clin Exp Immunol; 1993 Jun; 92(3):466-72. PubMed ID: 8513578
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 is involved in mouse resistance to Mycobacterium avium.
Denis M; Ghadirian E
Infect Immun; 1994 Feb; 62(2):457-61. PubMed ID: 8300206
[TBL] [Abstract][Full Text] [Related]
10. Role of CD40 ligand in Mycobacterium avium infection.
Hayashi T; Rao SP; Meylan PR; Kornbluth RS; Catanzaro A
Infect Immun; 1999 Jul; 67(7):3558-65. PubMed ID: 10377139
[TBL] [Abstract][Full Text] [Related]
11. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis.
Flórido M; Gonçalves AS; Silva RA; Ehlers S; Cooper AM; Appelberg R
Infect Immun; 1999 Jul; 67(7):3610-8. PubMed ID: 10377146
[TBL] [Abstract][Full Text] [Related]
12. Induction and expression of protective T cells during Mycobacterium avium infections in mice.
Appelberg R; Pedrosa J
Clin Exp Immunol; 1992 Mar; 87(3):379-85. PubMed ID: 1544223
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta (TGF-b1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence.
Denis M; Ghadirian E
Microb Pathog; 1991 Nov; 11(5):367-72. PubMed ID: 1816490
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Dec; 66(12):811-7. PubMed ID: 1784098
[TBL] [Abstract][Full Text] [Related]
15. Protection of mice from Mycobacterium avium infection by recombinant interleukin-12.
Kobayashi K; Kasama T; Yamazaki J; Hosaka M; Katsura T; Mochizuki T; Soejima K; Nakamura RM
Antimicrob Agents Chemother; 1995 Jun; 39(6):1369-71. PubMed ID: 7574533
[TBL] [Abstract][Full Text] [Related]
16. Suppressive activity of splenic macrophages induced by transparent and opaque colonial variants of Mycobacterium avium complex against lymphoproliferative response.
Tomioka H; Saito H
Microbiol Immunol; 1993; 37(6):477-83. PubMed ID: 8231963
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitro.
Hubbard RD; Collins FM
Infect Immun; 1991 Feb; 59(2):570-4. PubMed ID: 1898909
[TBL] [Abstract][Full Text] [Related]
18. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
Doherty TM; Sher A
J Immunol; 1997 May; 158(10):4822-31. PubMed ID: 9144497
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.
Appelberg R; Sarmento A; Castro AG
Clin Exp Immunol; 1995 Aug; 101(2):308-13. PubMed ID: 7648714
[TBL] [Abstract][Full Text] [Related]
20. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
Edwards CK; Hedegaard HB; Zlotnik A; Gangadharam PR; Johnston RB; Pabst MJ
J Immunol; 1986 Mar; 136(5):1820-7. PubMed ID: 3005400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
